Syros Pharmaceuticals (NASDAQ:SYRS) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the stock. A number of other equities analysts have also weighed in on the stock. Brookline Capital Management reissued a “hold” rating on shares of Syros Pharmaceuticals […]
StockNews.com started coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the stock. A number of other equities analysts have also weighed in on the stock. Brookline Capital Management reissued a “hold” rating on shares of Syros Pharmaceuticals […]